Viewing Study NCT04501120


Ignite Creation Date: 2025-12-25 @ 4:29 AM
Ignite Modification Date: 2025-12-26 @ 3:32 AM
Study NCT ID: NCT04501120
Status: RECRUITING
Last Update Posted: 2025-09-26
First Post: 2020-08-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML
Sponsor: Ascentage Pharma Group Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module